Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Blood ; 82(1): 126-34, 1993 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-8324216

RESUMO

Early thrombosis of artificial microvascular grafts (AMG, grafts < or = 2 mm internal diameter) prevents their reliable clinical use. The present studies were undertaken to examine the effect of hirudin, a thrombin-specific inhibitor, and of the F(ab')2 fragment of PG-1, a monoclonal antibody (MoAb) directed against guinea pig platelet membrane glycoprotein Ib (GPIb), on AMG patency in an animal model. One-centimeter long segments of expanded polytetrafluoroethylene (ePTFE), 0.88 mm internal diameter, were serially implanted as interposition grafts in the guinea pig femoral arterial systems bilaterally. A control group was treated with 0.5 mL saline intravenously (IV) 30 minutes before limb 1 and limb 2 graft implantation. Three experimental groups were treated with 0.5 mL saline IV before limb 1 graft implantation as an animal control and with either 0.5 mL saline containing 1.25 mg/kg IV PG-1 F(ab')2, (which inhibits ristocetin-induced platelet agglutination and von Willebrand factor binding), hirudin 1 mg/kg IV, or a combination of both agents before limb 2 graft implantation. GPIb inhibition, thrombin inhibition, and the combination resulted in a significant prolongation of AMG patency (P < .005). Whereas thrombin inhibition with hirudin prolonged AMG patency similar to that observed with GPIb inhibition, the combination of GPIb and thrombin inhibition provided the overall longest prolongation of AMG patency. These results indicate that both platelet membrane GPIb and thrombin play a role in AMG thrombosis.


Assuntos
Vasos Sanguíneos/transplante , Glicoproteínas da Membrana de Plaquetas/metabolismo , Trombose/etiologia , Trifosfato de Adenosina/farmacologia , Animais , Anticorpos Monoclonais , Cobaias , Hemostasia/efeitos dos fármacos , Hirudinas/farmacologia , Masculino , Microcirculação , Microscopia Eletrônica , Agregação Plaquetária/efeitos dos fármacos , Glicoproteínas da Membrana de Plaquetas/antagonistas & inibidores , Trombina/antagonistas & inibidores
2.
Plast Reconstr Surg ; 91(3): 522-7, 1993 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8438023

RESUMO

The propensity for platelets to bind at a native vessel anastomosis is thought to be related to subendothelial exposure, the presence of suture material, and local flow disturbances. By using an artificial microvascular graft to artificial microvascular graft anastomosis model that mimics the geometry and topography of a native microvascular anastomosis but which eliminates the endothelial and subendothelial contributions, the influence of the normal anastomotic configuration alone on initial platelet deposition was measured. Anastomotic and immediate downstream platelet deposition was not augmented by the presence of the anastomotic configuration alone. This suggests that the enhanced initial platelet deposition in the region of a native vessel microanastomosis is primarily related to the presence of injured endothelium and exposed subendothelium rather than to flow disturbances.


Assuntos
Anastomose Cirúrgica/métodos , Prótese Vascular , Microcirurgia/métodos , Agregação Plaquetária/fisiologia , Politetrafluoretileno , Combinação de Medicamentos , Hemostáticos/química , Humanos , Radioisótopos de Índio , Microscopia Eletrônica de Varredura , Modelos Cardiovasculares , Palmitatos/química , Adesividade Plaquetária/fisiologia , Contagem de Plaquetas , Politetrafluoretileno/química , Reologia , Propriedades de Superfície , Ceras/química
3.
Plast Reconstr Surg ; 90(4): 650-8, 1992 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-1410002

RESUMO

Initial platelet deposition (PD) in and around the region of a small-vessel anastomosis may set the stage for thrombosis and tissue loss. To study this problem, a human vessel model (human placental artery, HPA) has been designed to mimic the vascular injuries attendant on clinical microsurgery. To perform these studies, dissected lengths of human placental artery were treated to provide the following four types of injury: group I: control, dissected but otherwise uninjured (N = 5); group II: distal portion of vessel endothelium removed (N = 5); group III: central anastomosis, distal endothelium intact (N = 7); and group IV: central anastomosis, distal endothelium removed (N = 4). Vessels were perfused with 25 ml human whole blood for 17 +/- 5 s at an average shear rate of 536 s-1. Vessels in groups I to IV were segmented at 2-cm intervals, and the number of 111In-labeled platelets was measured. Data from the following groups of exposure zones were pooled and analyzed: endothelium intact, endothelium absent, anastomosis present, postanastomosis with endothelium intact, and postanastomosis with endothelium absent. Significant numbers of platelets were found to attach to intact endothelium, indicating that ischemia and microsurgical handling may augment platelet deposition to otherwise uninjured vessels. A similar degree of platelet deposition was measured after exposure of the subendothelium and perfusion, indicating that superficial subendothelial exposure in the absence of an additional prothrombotic stimulus may lead to no greater platelet deposition than occurs on slightly injured endothelium alone. Platelet deposition at anastomoses was strikingly elevated, although the anastomosis had no additive effect on platelet deposition to downstream endothelium.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Vasos Sanguíneos/fisiologia , Adesividade Plaquetária , Procedimentos Cirúrgicos Vasculares , Anastomose Cirúrgica , Vasos Sanguíneos/ultraestrutura , Endotélio Vascular/fisiologia , Humanos , Técnicas In Vitro , Microscopia Eletrônica de Varredura , Microcirurgia , Placenta/irrigação sanguínea , Fluxo Sanguíneo Regional
4.
Plast Reconstr Surg ; 88(5): 851-9, 1991 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1924572

RESUMO

Vasodilation of small blood vessels is controlled in part by the endothelium-derived relaxing factor (EDRF), which also inhibits platelet adhesion. Methylene blue (MB), which is occasionally applied directly to blood vessels during microsurgery to provide orientation and prevent torsion, is an irreversible inhibitor of the effects of endothelium-derived relaxing factor and may thereby augment both vasospasm and platelet responses. We have investigated the effects of the extravascular adventitial application of methylene blue on platelet deposition to human placental arteries (HPA) in the presence and absence of surgically induced vasospasm. A trend toward increased platelet deposition to human placental arteries was seen in each group but did not reach significance. The degree of platelet deposition to control human placental arteries suggests that the effects of methylene blue on platelet deposition may be dwarfed by the effects of surgical trauma and ischemia.


Assuntos
Artérias/efeitos dos fármacos , Plaquetas/efeitos dos fármacos , Azul de Metileno/farmacologia , Óxido Nítrico/antagonistas & inibidores , Vasoconstrição/efeitos dos fármacos , Administração Tópica , Etidocaína/farmacologia , Feminino , Humanos , Técnicas In Vitro , Azul de Metileno/administração & dosagem , Placenta/irrigação sanguínea , Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA